In summary, our findings suggest that cognitive activity may increase everyday functioning and BDNF levels, at least in a subset of vulnerable participants who began the 6-week intervention with low BDNF levels, which may help reduce the risk for cognitive decline and AD. This evidence concerns the gene BDNF and Mental deterioration.